Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 400 shares, a growth of 300.0% from the February 28th total of 100 shares. Based on an average trading volume of 3,200 shares, the short-interest ratio is presently 0.1 days.

Relief Therapeutics Stock Performance

OTCMKTS RLFTF traded down $0.32 on Thursday, reaching $2.54. The stock had a trading volume of 1,587 shares, compared to its average volume of 2,545. Relief Therapeutics has a 1-year low of $1.10 and a 1-year high of $7.66. The firm has a fifty day moving average of $3.58 and a two-hundred day moving average of $4.46.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.